Preparation method of stable magnesium-doped amorphous calcium phosphate nanoparticles

By adding magnesium ions into amorphous calcium phosphate and combining organic stabilizers, the problems of long preparation time and poor stability of amorphous calcium phosphate nanomaterials in the prior art were solved, and high biocompatibility and small Magnesium-doped amorphous calcium phosphate nanoparticles with particle size are suitable for a variety of biological applications, improving the stability of the material and drug loading efficiency.

CN118929595APending Publication Date: 2024-11-12KUNMING UNIV OF SCI & TECH
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202411212056.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-30
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing preparation methods of amorphous calcium phosphate nanomaterials have long time, poor stability and excessive particle size, resulting in low material activity and low drug load efficiency.

Method used

Stable magnesium doped amorphous calcium phosphate nanoparticles are prepared by combining magnesium ions into amorphous calcium phosphate, combined with organic stabilizers, and reacting under simple process conditions. The reaction time is short, the particle size is small, and the stability is high. .

Benefits of technology

A stable magnesium-doped amorphous calcium phosphate nanoparticles with high biocompatibility and biological activity in biological bodies were obtained. They are suitable for biocoatings, bioceramics and drug carriers, and improve the stability of materials and drug release performance. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118929595A_ABST
    Figure CN118929595A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method of stable magnesium-doped amorphous calcium phosphate nanoparticles, and relates to the technical field of preparation of medical biological materials, and the preparation method comprises the following steps: preparing an organic stabilizer aqueous solution, preparing a soluble calcium salt dispersion liquid, preparing a phosphate aqueous solution, and preparing the stable magnesium-doped amorphous calcium phosphate nanoparticles. The preparation method of the stable magnesium-doped amorphous calcium phosphate nanoparticles comprises the following steps: dispersing a soluble magnesium salt into a soluble calcium salt dispersion liquid, adding a phosphate aqueous solution, adjusting the pH value to obtain a milk white colloidal substance, and separating, washing and drying the milk white colloidal substance to obtain the product. The stable magnesium-doped amorphous calcium phosphate nano-material prepared by the method is white powder in appearance, uniform in morphology and relatively regular in particle shape in microstructure, the particle size distribution of nano-particles is 20-40nm, the particle size is relatively small, and corresponding aggregates have the characteristics of higher surface activity and porous structure, so that the stable magnesium-doped amorphous calcium phosphate nano-material can be used for preparing the magnesium-doped amorphous calcium phosphate nano-material. The application potential is shown in the fields of biological coatings, biological ceramics, drug carriers, stent materials and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of preparation of medical biomaterials, in particular to a method for preparing stable magnesium-doped amorphous calcium phosphate nanoparticles. Background Art

[0002] Among calcium phosphate materials, amorphous calcium phosphate (ACP) is a general term for calcium phosphates with short-range order, long-range disorder, and variable chemical composition (Ca / P atomic ratio can vary between 1.0-2.0). It is an amorphous intermediate phase that exists briefly when hydroxyapatite (HA) is synthesized by wet chemical method. X-ray diffraction analysis shows amorphous characteristics and is difficult to exist stably. Compared with hydroxyapatite (HA), ACP has better osteoconductivity and adhesion to osteoblasts in vivo; its degradation rate is also higher than tricalcium phosphate (TCP), and some properties can be adjusted by changing its components; at the same time, nano-ACP with excellent morphology and uniform particle size plays a very important role in biomineralization. As a mineral phase precursor, its isotropic properties give bone cavities stronger mechanical properties. Therefore, stable and available ACP nanomaterials have a wide range of uses and can be used as bio-coatings, bioceramics, drug carriers, scaffold materials, etc.

[0003] However, the preparation method of amorphous calcium phosphate nanomaterials in the prior art takes a long time, up to more than 30 minutes; and the amorphous calcium phosphate nanomaterials in the prior art have poor stability under high temperature conditions and a particle size of more than 100 nm, resulting in technical problems such as low material activity and low drug loading efficiency.

[0004] Therefore, it is necessary to study the preparation method of stable magnesium-doped amorphous calcium phosphate nanoparticles to solve the above technical problems. Summary of the invention

[0005] The purpose of the present invention is to provide a method for preparing stable magnesium-doped amorphous calcium phosphate nanoparticles, combining the advantages of excellent biocompatibility, biodegradability and biological activity of amorphous calcium phosphate in vivo, and doping magnesium ions into amorphous calcium phosphate to improve the comprehensive biological performance of the material and promote the efficient use of magnesium ions. The preparation process and conditions are simple, the reaction time is short, and the prepared magnesium-doped amorphous calcium phosphate nanoparticles have high stability, controllable morphology and size, and small size.

[0006] To achieve the above object, the present invention provides a method for preparing stable magnesium-doped amorphous calcium phosphate nanoparticles, comprising the following steps:

[0007] (1) preparing an organic stabilizer aqueous solution: taking an appropriate amount of an organic stabilizer raw material and adding it into deionized water, stirring and dissolving to obtain micelles, and ultrasonically treating the micelles to uniformly disperse the micelles to prepare an organic stabilizer aqueous solution;

[0008] (2) Preparation of a soluble calcium salt dispersion: dispersing a soluble calcium salt into the organic stabilizer aqueous solution prepared in step (1), stirring the mixture sufficiently to obtain an organic stabilizer soluble calcium salt dispersion;

[0009] (3) preparing a phosphate aqueous solution: weighing phosphate and adding it into deionized water, stirring and dissolving to obtain a phosphate aqueous solution;

[0010] (4) Preparation of stable magnesium-doped amorphous calcium phosphate nanoparticles: Disperse a soluble magnesium salt into the soluble calcium salt dispersion in step (2), add the phosphate aqueous solution in step (3) after mixing, and adjust the pH to above 9 for reaction. After the reaction is completed, a milky white colloidal substance is obtained. After separating, washing and drying the milky white colloidal substance, stable magnesium-doped amorphous calcium phosphate nanoparticles are obtained.

[0011] Magnesium ions are essential nutrients for the human body. They are mainly distributed in human bones and have excellent biological activity in promoting osteoblast proliferation, differentiation and angiogenesis. Therefore, in order to achieve efficient degradation of calcium phosphate materials in the body while having high biological activity and improve ion utilization, we incorporated magnesium ions into amorphous calcium phosphate (ACP), combined with the process and the incorporation of organic stabilizers, to prepare stable bioactive nanomaterials with corresponding excellent biological properties.

[0012] Furthermore, the purity of the organic stabilizer in step (1) is greater than 99.5%, and the organic stabilizer is one of gelatin, chitosan, and sodium alginate.

[0013] Furthermore, the stirring in step (1) is magnetic stirring, and the stirring rate of the magnetic stirring is 150-200 r / min; during ultrasonic treatment, the ultrasonic power is 200-250 W, and the ultrasonic time is 3-5 min.

[0014] The stirring in step (2) is carried out by magnetic stirring at a rate of 100 to 200 r / min until the mixture is completely dissolved.

[0015] The stirring in step (3) is carried out by magnetic stirring at a rate of 100 to 200 r / min until the mixture is completely dissolved.

[0016] Furthermore, the purity of the soluble calcium salt in step (2) is greater than 96%, and the soluble calcium salt is one of calcium nitrate and calcium chloride.

[0017] Furthermore, the purity of the phosphate in step (3) is greater than 99%, and the phosphate is one of ammonium hydrogen phosphate, disodium hydrogen phosphate, and sodium hydrogen phosphate.

[0018] Furthermore, the soluble magnesium salt in step (4) is one of magnesium citrate and magnesium chloride.

[0019] Furthermore, in step (4), the molar ratio of the soluble calcium salt to the phosphate is 0.5 to 1.5; and the molar ratio of the soluble magnesium salt to the soluble calcium salt is 0.1 to 0.3.

[0020] Furthermore, the washing in step (4) is cross-washing with deionized water and anhydrous ethanol for 2-3 times, the drying temperature is 40-80°C, and the drying time is 10-14h.

[0021] Furthermore, in step (4), concentrated aqueous ammonia is used to adjust the pH to above 9.

[0022] Furthermore, the reaction time in step (4) is 3 to 5 minutes.

[0023] 1. The method for preparing stable magnesium-doped amorphous calcium phosphate of the present invention has mild reaction conditions and can prepare magnesium-doped amorphous calcium phosphate nanoparticles with high stability and practical value at room temperature. The method has the advantages of simple equipment, cheap and readily available raw materials, safety and non-toxicity, simple process, extremely low reaction energy consumption, and feasibility of mass production.

[0024] 2. The stable magnesium-doped amorphous calcium phosphate nanomaterial prepared by the present invention has the appearance of a white powder with uniform morphology and relatively regular granules in microscopic morphology. The particle size distribution of the nanoparticles is between 20 and 40 nm, the particle size is small, and the corresponding agglomerates have higher surface activity and porous structure characteristics, showing application potential in the fields of biological coatings, bioceramics, drug carriers, scaffold materials, etc.

[0025] 3. The stable magnesium-doped amorphous calcium phosphate nanoparticles prepared by the present invention can stably exist for more than 14 days at 60° C. in a conventional atmosphere.

[0026] 4. The present invention uses protein macromolecules and polysaccharides as organic stabilizers, which are easy to control and can enhance the hydrophilicity of the prepared material. The prepared magnesium-doped amorphous calcium phosphate is also compounded with a small amount of organic molecules as stabilizers, which helps to further improve the ion release performance of the material itself in the body.

[0027] 5. The magnesium ions in the magnesium-doped amorphous calcium phosphate nanoparticles obtained by the present invention not only give the material better biological properties but also further enhance the stability of the material.

[0028] 6. The size and morphology of the magnesium-doped amorphous calcium phosphate nanoparticles obtained in the present invention can be adjusted by changing the system ion concentration, reaction time, stirring rate, etc.

[0029] 7. The preparation method of the present invention only takes 3-5 minutes to make the calcium salt and the phosphate react quickly to generate the target product, and at the same time, the magnesium salt is used to obtain a stable magnesium-doped amorphous calcium phosphate nanomaterial with an amorphous phase. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 The X-ray diffraction pattern (XRD) of the magnesium-doped amorphous calcium phosphate powder sample prepared in Example 1 of the present invention;

[0031] Figure 2 The X-ray diffraction pattern (XRD) of the powder sample of the magnesium-doped amorphous calcium phosphate prepared in Example 1 of the present invention after being stored at 60° C. in a conventional atmosphere for 14 days;

[0032] Figure 3 This is a scanning electron microscope image (SEM) of the magnesium-doped amorphous calcium phosphate powder sample prepared in Example 3 of the present invention;

[0033] Figure 4 This is a scanning electron microscope image (SEM) of the magnesium-doped amorphous calcium phosphate powder sample prepared in Example 3 of the present invention;

[0034] Figure 5 A scanning electron microscope image (SEM) of the magnesium-doped amorphous calcium phosphate powder sample prepared in Example 4 of the present invention;

[0035] Figure 6 A scanning electron microscope image (SEM) of the magnesium-doped amorphous calcium phosphate powder sample prepared in Example 4 of the present invention;

[0036] Figure 7 This is a scanning electron microscope image (SEM) of the magnesium-doped hydroxyapatite powder sample prepared in Comparative Example 1 of the present invention;

[0037] Figure 8 X-ray diffraction patterns (XRD) of magnesium-doped hydroxyapatite powder samples prepared in Comparative Examples 1 and 2 of the present invention;

[0038] Fig. 9 This is a scanning electron microscope image (SEM) of the magnesium-doped brushite sample prepared in Comparative Example 3;

[0039] Fig.10 The X-ray diffraction patterns (XRD) of the magnesium-doped brushite powder samples prepared in Comparative Examples 3 and 4. DETAILED DESCRIPTION

[0040] Embodiments of the present invention are described in detail below, examples of which are shown in the accompanying drawings, wherein the same or similar reference numerals throughout represent the same or similar elements or elements having the same or similar functions. The embodiments described below with reference to the accompanying drawings are exemplary and are intended to be used to explain the present invention, and are not to be construed as limitations of the present invention. In the description of the present invention, the meaning of "multiple" is two or more, unless otherwise clearly and specifically defined.

[0041] Example 1

[0042] A method for preparing stable magnesium-doped amorphous calcium phosphate nanoparticles comprises the following steps:

[0043] (1) preparing a gelatin aqueous solution: taking an appropriate amount of gelatin granules and adding them into deionized water, stirring them thoroughly to dissolve them, and ultrasonicating them to uniformly disperse the micelles, and preparing 500 ml of a gelatin aqueous solution with a mass concentration of 1% wt;

[0044] Among them, the stirring rate is 150r / min, the ultrasonic power is 200W, and the ultrasonic time is 3min.

[0045] (2) Preparation of soluble calcium salt solution: Disperse calcium nitrate tetrahydrate into the gelatin aqueous solution obtained in step (1), stir thoroughly at a stirring rate of 100 r / min, and obtain a mixed solution with a calcium ion concentration of 100 mM;

[0046] (3) Preparation of phosphate aqueous solution: Weigh an appropriate amount of ammonium hydrogen phosphate and add it to deionized water, stir thoroughly to dissolve, and stir at a rate of 100 r / min to obtain 500 ml of an aqueous solution with a phosphate ion concentration of 75 mM;

[0047] (4) Preparation of stable magnesium-doped amorphous calcium phosphate nanoparticles: magnesium chloride is dispersed into the gelatin-calcium chloride mixed solution prepared in step (2) so that the molar ratio of calcium ions to magnesium ions is 1:0.1, and the mixture is stirred at a rate of 300 r / min. The phosphate solution prepared in step (3) is then slowly added, and the pH of the mixed phase is adjusted to above 9 with concentrated ammonia water. The mixture is stirred for 5 min. After stirring, a milky white colloidal substance is obtained. The colloidal substance is divided into centrifuge tubes and centrifuged at 5000 rpm for 3 min. After obtaining a white precipitate, the mixture is cross-washed twice with deionized water and anhydrous ethanol respectively, and dried in a 60°C forced air drying oven for 12 h to obtain the material.

[0048] Figure 1 The X-ray diffraction pattern (XRD) of the magnesium-doped amorphous calcium phosphate powder sample prepared in Example 1 of the present invention is as follows: Figure 2 This is the X-ray diffraction pattern (XRD) of the powder sample of magnesium-doped amorphous calcium phosphate prepared in Example 1 of the present invention after being heated at 60°C in a normal atmosphere for 14 days. Figure 1It can be seen from the XRD pattern of the sample that the typical amorphous calcium phosphate amorphous bun peaks; Figure 2 It can be seen that under conventional atmosphere at 60°C, its XRD pattern did not change significantly after 14 days.

[0049] Example 2

[0050] A method for preparing stable magnesium-doped amorphous calcium phosphate nanoparticles comprises the following steps:

[0051] (1) preparing a gelatin aqueous solution: taking an appropriate amount of gelatin granules and adding them into deionized water, stirring them thoroughly to dissolve them, and ultrasonicating them to uniformly disperse the micelles, and preparing 500 ml of a gelatin aqueous solution with a mass concentration of 1% wt;

[0052] Among them, the stirring rate is 150r / min, the ultrasonic power is 220W, and the ultrasonic time is 4min.

[0053] (2) Preparation of soluble calcium salt solution: Disperse calcium nitrate tetrahydrate into the gelatin aqueous solution obtained in step 1, stir thoroughly at a stirring rate of 150 r / min, and obtain a mixed solution with a calcium ion concentration of 100 mM;

[0054] (3) Preparation of phosphate aqueous solution: Weigh an appropriate amount of sodium dihydrogen phosphate and add it to deionized water, stir thoroughly to dissolve, and stir at a rate of 150 r / min to obtain 500 ml of an aqueous solution with a phosphate ion concentration of 75 mM;

[0055] (4) Preparation of stable magnesium-doped amorphous calcium phosphate nanoparticles: magnesium chloride was dispersed into the gelatin-calcium chloride mixed solution prepared in step 2, so that the molar ratio of calcium ions to magnesium ions was 1:0.1, and the mixture was stirred thoroughly at a stirring rate of 350 r / min. The phosphate solution prepared in step 3 was then slowly added, and the pH of the mixed phase was adjusted to above 9 with concentrated ammonia water. The mixture was stirred for 5 min. After stirring, a milky white colloidal substance was obtained. The colloidal substance was divided into centrifuge tubes and centrifuged at 5000 rpm for 3 min. After obtaining a white precipitate, the mixture was cross-washed twice with deionized water and anhydrous ethanol respectively, and dried in a 60°C forced air drying oven for 14 h to obtain the material.

[0056] Example 3

[0057] A method for preparing stable magnesium-doped amorphous calcium phosphate nanoparticles comprises the following steps:

[0058] (1) preparing a gelatin aqueous solution: taking an appropriate amount of gelatin granules and adding them into deionized water, stirring them thoroughly to dissolve them, and ultrasonicating them to uniformly disperse the micelles, and preparing 500 ml of a gelatin aqueous solution with a mass concentration of 1% wt;

[0059] Among them, the stirring rate is 180r / min, the ultrasonic power is 225W, and the ultrasonic time is 5min.

[0060] (2) Preparation of soluble calcium salt solution: Disperse anhydrous calcium chloride into the gelatin aqueous solution obtained in step 1, stir thoroughly at a stirring rate of 150 r / min, and obtain a mixed solution with a calcium ion concentration of 100 mM;

[0061] (3) Preparation of phosphate aqueous solution: Weigh an appropriate amount of sodium dihydrogen phosphate and add it to deionized water, stir thoroughly to dissolve, and stir at a rate of 150 r / min to prepare 500 ml of an aqueous solution with a phosphate ion concentration of 100 mM;

[0062] (4) Preparation of stable magnesium-doped amorphous calcium phosphate nanoparticles: Disperse magnesium citrate into the gelatin-calcium chloride mixed solution prepared in step 2 so that the molar ratio of calcium ions to magnesium ions is 1:0.2, stir thoroughly at a stirring rate of 350 r / min, then slowly add the phosphate solution prepared in step 3, and adjust the pH of the mixed phase to above 9 with concentrated ammonia water, stir for 3 minutes, and obtain a milky white colloidal substance after stirring. The colloidal substance is divided into centrifuge tubes, centrifuged at 5000 rpm for 3 minutes, and after obtaining a white precipitate, it is cross-washed with deionized water and anhydrous ethanol for 3 times, respectively, and placed in an 80°C forced air drying oven for 10 hours to obtain the material.

[0063] Figure 3 This is a scanning electron microscope image (SEM) of the magnesium-doped amorphous calcium phosphate powder sample prepared in Example 3 of the present invention; Figure 4 This is a scanning electron microscope image (SEM) of the magnesium-doped amorphous calcium phosphate powder sample prepared in Example 3 of the present invention. Figure 3 It can be seen that the sample is agglomerated; Figure 4 It can be seen that the particle size distribution of amorphous calcium phosphate nanoparticles is between 20 and 40 nm.

[0064] Example 4

[0065] A method for preparing stable magnesium-doped amorphous calcium phosphate nanoparticles comprises the following steps:

[0066] (1) preparing a gelatin aqueous solution: taking an appropriate amount of gelatin granules and adding them into deionized water, stirring them thoroughly to dissolve them, and ultrasonicating them to uniformly disperse the micelles, and preparing 500 ml of a gelatin aqueous solution with a mass concentration of 1% wt;

[0067] Among them, the stirring rate is 180r / min, the ultrasonic power is 225W, and the ultrasonic time is 5min.

[0068] (2) Preparation of soluble calcium salt solution: Disperse anhydrous calcium chloride into the gelatin aqueous solution obtained in step 1, stir thoroughly at a stirring rate of 150 r / min, and obtain a mixed solution with a calcium ion concentration of 100 mM;

[0069] (3) Preparation of phosphate aqueous solution: Weigh an appropriate amount of disodium hydrogen phosphate and add it to deionized water, stir thoroughly to dissolve, and stir at a rate of 150 r / min to prepare 500 ml of an aqueous solution with a phosphate ion concentration of 100 mM;

[0070] (4) Preparation of stable magnesium-doped amorphous calcium phosphate nanoparticles: Disperse magnesium citrate into the gelatin-calcium chloride mixed solution prepared in step 2 so that the molar ratio of calcium ions to magnesium ions is 1:0.1, stir thoroughly at a stirring rate of 300 r / min, then slowly add the phosphate solution prepared in step 3, and adjust the pH of the mixed phase to above 9 with concentrated ammonia water. Stir for 3 minutes. After stirring, a milky white colloidal substance is obtained. The colloidal substance is divided into centrifuge tubes and centrifuged at 5000 rpm for 5 minutes to obtain a white precipitate. The precipitate is then cross-washed three times with deionized water and anhydrous ethanol, respectively, and dried in a 40°C forced air drying oven for 12 hours to obtain the material.

[0071] Figure 5 A scanning electron microscope image (SEM) of the magnesium-doped amorphous calcium phosphate powder sample prepared in Example 4 of the present invention; Figure 6 The scanning electron microscope (SEM) image of the magnesium-doped amorphous calcium phosphate powder sample prepared in Example 4 of the present invention; Figure 5 It can be seen that the sample is agglomerated; Figure 6 It can be seen that the particle morphology of the sample is significantly different from that of the sample prepared in Example 3.

[0072] Example 5

[0073] A method for preparing stable magnesium-doped amorphous calcium phosphate nanoparticles comprises the following steps:

[0074] (1) Preparation of chitosan aqueous solution: Take an appropriate amount of chitosan powder raw material and add it to deionized water, stir it thoroughly to dissolve, and ultrasonicate it to make the micelles evenly dispersed, and prepare 500 ml of chitosan aqueous solution with a mass concentration of 2% wt;

[0075] Among them, the stirring rate is 200r / min, the ultrasonic power is 250W, and the ultrasonic time is 5min.

[0076] (2) Preparation of soluble calcium salt solution: Disperse anhydrous calcium chloride into the chitosan aqueous solution obtained in step 1, stir thoroughly at a stirring rate of 150 r / min, and obtain a mixed solution with a calcium ion concentration of 100 mM;

[0077] (3) Preparation of phosphate aqueous solution: Weigh an appropriate amount of disodium hydrogen phosphate and add it to deionized water, stir thoroughly to dissolve, and stir at a rate of 150 r / min to prepare 500 ml of an aqueous solution with a phosphate ion concentration of 100 mM;

[0078] (4) Preparation of stable magnesium-doped amorphous calcium phosphate nanoparticles: Magnesium citrate was dispersed into the chitosan-calcium chloride mixed solution prepared in step 2, so that the molar ratio of calcium ion to magnesium ion was 1:0.3, and the mixture was stirred thoroughly at a stirring rate of 300 r / min. The phosphate solution prepared in step 3 was then slowly added, and the pH of the mixed phase was adjusted to above 9 with concentrated ammonia water. The mixture was stirred for 3 min. After stirring, a milky white colloidal substance was obtained. The colloidal substance was divided into centrifuge tubes and centrifuged at 5000 rpm for 3 min. After obtaining a white precipitate, the mixture was cross-washed twice with deionized water and anhydrous ethanol respectively, and dried in a 50°C forced air drying oven for 12 h to obtain the material.

[0079] Example 6

[0080] A method for preparing stable magnesium-doped amorphous calcium phosphate nanoparticles comprises the following steps:

[0081] (1) preparing sodium alginate aqueous solution: taking an appropriate amount of sodium alginate powder raw material, adding it into deionized water, stirring it thoroughly to dissolve it, and ultrasonicating it to make the micelles evenly dispersed, and preparing 500 ml of sodium alginate aqueous solution with a mass concentration of 2% wt;

[0082] Among them, the stirring rate is 200r / min, the ultrasonic power is 250W, and the ultrasonic time is 5min.

[0083] (2) Preparation of soluble calcium salt solution: Disperse anhydrous calcium chloride into the sodium alginate aqueous solution obtained in step 1, stir thoroughly at a stirring rate of 150 r / min, and obtain a mixed solution with a calcium ion concentration of 100 mM;

[0084] (3) Preparation of phosphate aqueous solution: Weigh an appropriate amount of disodium hydrogen phosphate and add it to deionized water, stir thoroughly to dissolve, and stir at a rate of 150 r / min to obtain 500 ml of an aqueous solution with a phosphate ion concentration of 67 mM;

[0085] (4) Preparation of stable magnesium-doped amorphous calcium phosphate nanoparticles: Disperse magnesium citrate into the sodium alginate and calcium chloride mixed solution prepared in step 2 so that the molar ratio of calcium ions to magnesium ions is 1:0.3, stir thoroughly at a stirring rate of 300 r / min, then slowly add the phosphate solution prepared in step 3, and adjust the pH of the mixed phase to above 9 with concentrated ammonia water, stir for 4 minutes, and obtain a milky white colloidal substance after stirring. The colloidal substance is divided into centrifuge tubes, centrifuged at 5000 rpm for 3 minutes, and after obtaining a white precipitate, it is cross-washed with deionized water and anhydrous ethanol for 3 times, respectively, and placed in a 50°C forced air drying oven for 12 hours to obtain the material.

[0086] Comparative Example 1

[0087] A method for preparing magnesium-doped hydroxyapatite comprises the following steps:

[0088] (1) Preparation of soluble calcium salt solution: Dissolve calcium nitrate tetrahydrate in deionized water and stir thoroughly at a stirring rate of 100 r / min to obtain 500 ml of an aqueous solution with a calcium ion concentration of 100 mM;

[0089] (2) Preparation of phosphate aqueous solution: Weigh an appropriate amount of ammonium hydrogen phosphate and add it to deionized water, stir thoroughly to dissolve, and stir at a rate of 100 r / min to obtain 500 ml of an aqueous solution with a phosphate ion concentration of 75 mM;

[0090] (3) Preparation of stable magnesium-doped amorphous calcium phosphate nanoparticles: Disperse magnesium citrate into the solution prepared in step 1 so that the molar ratio of calcium ion to magnesium ion is 1:0.2, stir thoroughly at a stirring rate of 300 r / min, then slowly add the phosphate solution prepared in step 2, and adjust the pH of the mixed phase to above 9 with concentrated ammonia water, stir for 3 min, and obtain a milky white colloidal substance after stirring. The colloidal substance is divided into centrifuge tubes and centrifuged at 5000 rpm for 3 min to obtain a white precipitate, which is then cross-washed twice with deionized water and anhydrous ethanol respectively, and dried in a 60°C forced air drying oven for 12 h to obtain a magnesium-doped hydroxyapatite material.

[0091] Figure 7 This is a scanning electron microscope image (SEM) of the magnesium-doped hydroxyapatite powder sample prepared in this comparative example 1. Figure 7 It can be seen that the sample particle size distribution is between 5-20μm.

[0092] Comparative Example 2

[0093] A method for preparing magnesium-doped hydroxyapatite comprises the following steps:

[0094] (1) Preparation of soluble calcium salt solution: Dissolve calcium nitrate tetrahydrate in deionized water and stir thoroughly at a stirring rate of 100 r / min to obtain 500 ml of an aqueous solution with a calcium ion concentration of 100 mM;

[0095] (2) Preparation of phosphate aqueous solution: Weigh an appropriate amount of sodium dihydrogen phosphate and add it to deionized water, stir thoroughly to dissolve, and stir at a rate of 150 r / min to obtain 500 ml of an aqueous solution with a phosphate ion concentration of 75 mM;

[0096] (3) Preparation of stable magnesium-doped amorphous calcium phosphate nanoparticles: Disperse magnesium citrate into the solution prepared in step 1 so that the molar ratio of calcium ion to magnesium ion is 1:0.2, stir thoroughly at a stirring rate of 350 r / min, then slowly add the phosphate solution prepared in step 2, and adjust the pH of the mixed phase to above 9 with concentrated ammonia water. Stir for 30 min. After stirring, a milky white suspension is obtained. The material is divided into centrifuge tubes and centrifuged at 5000 rpm for 3 min. After obtaining a white precipitate, it is cross-washed twice with deionized water and anhydrous ethanol respectively, and dried in a 60°C forced air drying oven for 14 h to obtain a magnesium-doped hydroxyapatite material.

[0097] Figure 8 The X-ray diffraction patterns (XRD) of the magnesium-doped hydroxyapatite powder samples prepared in Comparative Example 1 and Comparative Example 2 are shown in FIG. Figure 8 It can be seen that changing the reaction stirring time has no obvious effect on the reaction product.

[0098] Comparative Example 3

[0099] A method for preparing brushite comprises the following steps:

[0100] (1) Preparation of soluble calcium salt solution: dissolve anhydrous calcium chloride in deionized water and stir thoroughly at a stirring rate of 150 r / min to obtain 500 ml of an aqueous solution with a calcium ion concentration of 100 mM;

[0101] (2) Preparation of phosphate aqueous solution: Weigh an appropriate amount of sodium dihydrogen phosphate and add it to deionized water, stir thoroughly to dissolve, and stir at a rate of 150 r / min to obtain 500 ml of an aqueous solution with a phosphate ion concentration of 100 mM;

[0102] (3) Preparation of stable magnesium-doped amorphous calcium phosphate nanoparticles: Disperse magnesium chloride into the solution prepared in step 1 so that the molar ratio of calcium ions to magnesium ions is 1:0.1, stir thoroughly at a stirring rate of 350 r / min, then slowly add the phosphate solution prepared in step 2, and adjust the pH of the mixed phase to above 9 with concentrated ammonia water, stir for 3 minutes, and obtain a milky white suspension after stirring. The colloidal substance is divided into centrifuge tubes, centrifuged at 5000 rpm for 3 minutes, and after obtaining a white precipitate, it is cross-washed with deionized water and anhydrous ethanol for 3 times, respectively, and placed in an 80°C forced air drying oven for 10 hours to obtain the material.

[0103] Fig. 9 This is a scanning electron microscope image (SEM) of the magnesium-doped brushite sample prepared in Comparative Example 3. Fig. 9 It can be seen that the sample appears to be an uneven agglomerate.

[0104] Comparative Example 4

[0105] (1) Preparation of soluble calcium salt solution: dissolve anhydrous calcium chloride in deionized water and stir thoroughly at a stirring rate of 150 r / min to obtain 500 ml of an aqueous solution with a calcium ion concentration of 100 mM;

[0106] (2) Preparation of phosphate aqueous solution: Weigh an appropriate amount of sodium dihydrogen phosphate and add it to deionized water, stir thoroughly to dissolve, and stir at a rate of 150 r / min to obtain 500 ml of an aqueous solution with a phosphate ion concentration of 100 mM;

[0107] (3) Preparation of stable magnesium-doped amorphous calcium phosphate nanoparticles: Disperse magnesium chloride into the solution prepared in step 1 so that the molar ratio of calcium ions to magnesium ions is 1:0.1, stir thoroughly at a stirring rate of 350 r / min, then slowly add the phosphate solution prepared in step 2, and adjust the pH of the mixed phase to above 9 with concentrated ammonia water, stir for 30 minutes, and after stirring, a milky white suspension is obtained. The colloidal substance is divided into centrifuge tubes, centrifuged at 5000 rpm for 3 minutes, and after obtaining a white precipitate, it is cross-washed with deionized water and anhydrous ethanol for 3 times, respectively, and placed in an 80°C forced air drying oven for 10 hours to obtain the material.

[0108] Fig.10 The X-ray diffraction patterns (XRD) of the magnesium-doped brushite powder samples prepared in Comparative Examples 3 and 4 are as follows: Fig.10 It can be seen that changing the reaction stirring time has no obvious effect on the reaction product.

[0109] Comparative Example 5

[0110] Amorphous calcium phosphate nanospheres and a preparation method thereof, comprising the following steps:

[0111] At room temperature, 0.1470 g of CaCl2·H2O was dissolved in 30 ml of deionized water to form solution A, and 0.1102 g of adenosine triphosphate disodium salt hydrate was dissolved in 10 ml of deionized water to form solution B. After adjusting solution A to pH 5 with 1 mol / L hydrochloric acid, solution B was added dropwise, and magnetic stirring was used during the process to keep the pH value at about 5. After the addition was completed, the mixed clarified solution was transferred to a microwave reactor (with a capacity of 60 ml) and reacted at 100°C for 30 minutes. After the reaction system was naturally cooled to room temperature, the product was taken out and centrifuged, and the separated product was washed 3 times with deionized water, washed once with anhydrous ethanol, and dried in air at 60°C to obtain calcium phosphate nanosphere powder. The average diameter of the amorphous calcium phosphate nanosphere was 260 nm.

[0112] In summary, the prepared stable magnesium-doped amorphous calcium phosphate nanomaterial has a white powder appearance, a uniform morphology, and a relatively regular granular shape in microscopic morphology. The nanoparticle size distribution is between 20 and 40 nm, the particle size is small, and the corresponding agglomerates have higher surface activity and porous structure characteristics, showing application potential in the fields of biological coatings, bioceramics, drug carriers, scaffold materials, etc. The preparation method of the present invention only takes 3-5 minutes to make the calcium salt and the phosphate react quickly to generate the target product, and at the same time, the amorphous stable magnesium-doped amorphous calcium phosphate nanomaterial is obtained after the magnesium salt.

[0113] The above disclosure is only part of the embodiments of the present invention, which cannot be used to limit the scope of the present invention. Ordinary technicians in this field can understand that all or part of the processes of the above embodiments and equivalent changes made according to the claims of the present invention are still within the scope of the invention.

Claims

1. A method for preparing stable magnesium-doped amorphous calcium phosphate nanoparticles, Features: The steps include: (1) preparing an organic stabilizer aqueous solution: taking an appropriate amount of an organic stabilizer raw material and adding it to deionized water, stirring and dissolving to obtain micelles, and ultrasonically treating the micelles to uniformly disperse the micelles to prepare an organic stabilizer aqueous solution; (2) Preparation of a soluble calcium salt dispersion: dispersing the soluble calcium salt into the organic stabilizer aqueous solution prepared in step (1), stirring the solution sufficiently to obtain an organic stabilizer soluble calcium salt dispersion; (3) Preparation of phosphate aqueous solution: weigh phosphate and add it into deionized water, stirring and dissolving to obtain a phosphate aqueous solution; (4) Preparation of stable magnesium-doped amorphous calcium phosphate nanoparticles: Disperse a soluble magnesium salt into the soluble calcium salt dispersion in step (2), add the phosphate aqueous solution in step (3) after mixing, and adjust the pH to above 9 to react. After the reaction is completed, a milky white colloidal substance is obtained. After separating, washing and drying the milky white colloidal substance, stable magnesium-doped amorphous calcium phosphate nanoparticles are obtained.

2. The method for preparing the stable magnesium-doped amorphous calcium phosphate nanoparticles according to claim 1, It is characterized in that The organic stabilizer in step (1) is one of gelatin, chitosan and sodium alginate.

3. The method for preparing the stable magnesium-doped amorphous calcium phosphate nanoparticles according to claim 1, It is characterized in that The stirring rate of the stirring in step (1) is 150-200 r / min; during ultrasonic treatment, the ultrasonic power is 200-250 W, and the ultrasonic time is 3-5 min.

4. The method for preparing the stable magnesium-doped amorphous calcium phosphate nanoparticles according to claim 1, It is characterized in that The soluble calcium salt in step (2) is one of calcium nitrate and calcium chloride.

5. The method for preparing the stable magnesium-doped amorphous calcium phosphate nanoparticles according to claim 1, It is characterized in that The phosphate in step (3) is one of ammonium hydrogen phosphate, sodium dihydrogen phosphate and disodium hydrogen phosphate.

6. The method for preparing the stable magnesium-doped amorphous calcium phosphate nanoparticles according to claim 1, It is characterized in that The soluble magnesium salt in step (4) is one of magnesium citrate and magnesium chloride.

7. The method for preparing the stable magnesium-doped amorphous calcium phosphate nanoparticles according to claim 1, It is characterized in that In step (4), the molar ratio of the soluble calcium salt to the phosphate is 1.0-1.5; the molar ratio of the soluble magnesium salt to the soluble calcium salt is 0.1-0.

3.

8. The method for preparing the stable magnesium-doped amorphous calcium phosphate nanoparticles according to claim 1, It is characterized in that The washing in step (4) is cross-washing with deionized water and anhydrous ethanol for 2-3 times, the drying temperature is 40-80°C, and the drying time is 10-14h.

9. The method for preparing the stable magnesium-doped amorphous calcium phosphate nanoparticles according to claim 1, It is characterized in that In step (4), concentrated ammonia water is used to adjust the pH to above 9.

10. The method for preparing the stable magnesium-doped amorphous calcium phosphate nanoparticles according to claim 1, It is characterized in that The reaction time in step (4) is 3 to 5 minutes.

Citation Information

Patent Citations

  • Preparation method for amorphous calcium phosphate nanospheres

    CN104860284A

  • Amorphous magnesium-substituted calcium phosphate compositions and their uses

    CN105722504A

  • Preparation method and application of high-stability bioactive amorphous calcium magnesium phosphate

    CN116768175A

  • Method for preparing nano amorphous calcium phosphate powder

    CN1935636A

  • Calcium phosphate colloids, dots, islands, thin films or granules and its preparation

    US20050026003A1